Abstract: Hydrophilic coatings for implantable ophthalmic lenses are disclosed. The coatings, which are applied to the edge surface of the ophthalmic lens, comprise a hydrophobic (meth)acrylic polymer and a hydrophilic polymer. When hydrated, the coatings reduce or eliminate edge glare.

Abstract: A handpiece having at least one set of piezoelectric elements. The piezoelectric elements are constructed of segments that produce both longitudinal and torsional motion. An appropriate ultrasound driver drives the set of elements at the respective resonant frequencies to product longitudinal vibration and torsional oscillation.

Abstract: An intraocular lens injector cartridge having a heat retention additive for helping the cartridge retain heat once the cartridge is warmed. Such additives can include an biocompatible material having high heat retention, for example, powdered gold.

Abstract: Methods and compositions for preventing or treating allergic diseases of the eye, nose, skin, ear, gastrointestinal tract, airways or lung and preventing or treating manifestations of systemic mastocytosis are disclosed. The compositions contain a mast cell stabilizing disulfide derivative as an active ingredient.

Abstract: An automated focusing method for a wavefront sensor that iteratively determines the best optics setting for the wavefront sensor by making objective measurements of the patient's focus without the need for subjective information from the patient.

Abstract: An anterior chamber phakic lens made from an elastomeric, foldable, highly biocompatible material. The lens has a generally circular optic and integrally formed plate-style haptics, the haptics containing an opening into which project a pair of pincer arms. The pincer arms are sized and shaped so as to pull away from each other when the lens is folded, and are draw back toward each other when the folded lens is released and allowed to return to its unfolded state. Such movement allows the pincers to gather a small section of the iris so as to hold the lens in place.

Abstract: Novel disulfide derivatives useful for preventing or treating allergic diseases of the eye, nose, skin, ear, gastrointestinal tract, airways or lung and preventing or treating manifestations of systemic mastocytosis are disclosed. The disulfide derivatives act as mast cell stabilizers.

Abstract: Hydrophilic coatings for implants are disclosed. The coatings are hydrophobically bound to the implant, but are not covalently cross-linked or covalently anchored to the implant's surface.

Abstract: The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders is disclosed.

Abstract: Topically administrable anti-allergy compositions comprising olopatadine and a polymeric quaternary ammonium preservative are suitable for use by patients wearing contact lenses.

Abstract: Methods and compositions for preventing or treating allergic diseases of the eye, nose, skin, ear, gastrointestinal tract, airways or lung and preventing or treating manifestations of systemic mastocytosis are disclosed. The compositions contain a mast cell stabilizing disulfide derivative as an active ingredient.

Abstract: This invention is directed toward a method of preparing a topical composition comprising ciprofloxacin and hydrocortisone. The method involves dispersing hydrocortisone with lecithin for greater than 45 minutes prior to combining hydrocortisone with the balance of the composition.

Abstract: This invention is directed toward a topical composition comprising ciprofloxacin and hydrocortisone, where the composition contains a specific grade of polyvinyl alcohol as a viscosity augmenter. The specified grade of polyvinyl alcohol is 85-90% hydrolyzed polyvinyl alcohol.

Abstract: Stable aqueous pharmaceutical suspension compositions containing lecithin as a stabilizing additive and lacking a polymeric suspending agent are disclosed.

Abstract: The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat angiogenesis-related disorders, including ophthalmic angiogenesis-related disorders such as diabetic retinopathy and exudative macular degeneration, is disclosed.

Abstract: Topically administrable aqueous solution compositions containing tobramycin and xanthan gum are disclosed. The solution compositions contain a buffering agent and a pH-adjusting agent in an amount sufficient to achieve a pH above 7.8 in order to minimize or avoid compatibility problems between tobramycin and xanthan gum.

Abstract: A microsurgical instrument that includes a handle and a dissecting tip coupled to the handle is disclosed. The tip includes a blade having a generally elliptical three-dimensional geometry. The blade may include an edge having a first arc and an opposing second arc. When the instrument is used to form an intracorneal pocket for the implantation of an intracorneal optical lens, the curvature of the first arc allows the edge to dissect a first blind spot of the pocket, and the curvature of the second arc allows the edge to dissect a second blind spot of the pocket. The blade may also be formed with a first depression in its top surface and a second depression in its bottom surface. When the instrument is used to form an intracorneal pocket, the depressions reduce the drag on, and corresponding trauma to, stromal tissue.

Abstract: Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.

Abstract: A microsurgical instrument having a handle and a dissecting tip coupled to the handle is disclosed. The handle includes a cannula for transporting surgical fluid. The dissecting tip includes a blade for dissecting tissue and an aperture for delivering the fluid. The instrument may be used to more effectively create an intracorneal pocket for the implantation of an intracorneal optical lens.